Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2023-01-17 00:00:00 ET · period of report 2023-01-12 · accession 0001209191-23-003554 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-17 | 2023-01-12 | ACAD | Brege Laura | Dir | M - OptEx | $17.01 | +12.5K | 12.5K | New | +$212.6K |
| D | 2023-01-17 | 2023-01-12 | ACAD | Brege Laura | Dir | S - Sale+OE | $18.25 | -12.5K | 0 | -100% | -$228.1K |
| D | 2023-01-17 | 2023-01-12 | ACAD | Brege Laura | Dir | M - OptEx | $0.00 | -12.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-12 | M | A | 12,500 | $17.01 | 12,500 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-12 | S | D | 12,500 | $18.25 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-01-12 | M | D | 12,500 | $0.00 | 0 | D | $17.01 · — to 2023-06-06 | 12,500 Common Stock | (F2) The option is fully vested and exercisable. |